Leijun Hu

Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial

Clemens Becker, Stephen R. Lord, Stephanie A. Studenski et al. · The Lancet Diabetes & Endocrinology · 2015 · 353 citations

Older Weak Fallers, Autoimmune Disease, Immunology +5

A Randomized, Double-Blind Phase 2 Clinical Trial of Blosozumab, a Sclerostin Antibody, in Postmenopausal Women with Low Bone Mineral Density

Robert R. Recker, Charles Benson, Toshio Matsumoto et al. · Journal of Bone and Mineral Research · 2014 · 288 citations · Full text

Single- and Multiple-Dose Randomized Studies of Blosozumab, a Monoclonal Antibody Against Sclerostin, in Healthy Postmenopausal Women

Juliet McColm, Leijun Hu, Theresa Womack et al. · Journal of Bone and Mineral Research · 2013 · 173 citations · Full text

The Effect of Discontinuing Treatment With Blosozumab: Follow-up Results of a Phase 2 Randomized Clinical Trial in Postmenopausal Women With Low Bone Mineral Density

Christopher Recknor, Robert R. Recker, Charles Benson et al. · Journal of Bone and Mineral Research · 2015 · 76 citations · Full text

Intraprostatic Chemotherapy: Distribution and Transport Mechanisms

M. Guillaume Wientjes, Jenny Zheng, Leijun Hu et al. · Clinical Cancer Research · 2005 · 26 citations · Full text